Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Lambert

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 23, 2008
Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptorsMassimo Ibba, Masato Kitayama, John McDonald, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 4, 2007
Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamineZoë L S Brookes, Emily N Stedman, Remo Guerrini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 2014
Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladderEvangelia Bakali, Ruth A Elliott, Anthony H Taylor, et al.
Neuroscience Letters|April 4, 2003
Lack of an interaction between orexinergic and opioid/nociceptinergic systems in rat cerebrocortical slicesKazuyoshi Hirota, Tetsuya Kushikata, Mihoko Kudo, et al.
Journal of Neurochemistry|April 20, 2007
Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell deathPatricia M W Lam, Atticus H Hainsworth, Graham D Smith, et al.
Molecules (Basel, Switzerland)|December 30, 2020
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor ActivationJustyna Piekielna-Ciesielska, Roberto Artali, Ammar A H Azzam, et al.
CNS Drug Reviews|July 12, 2005
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptorGirolamo Calo, Remo Guerrini, Anna Rizzi, et al.
Anesthesia and Analgesia|September 28, 2007
Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptorsJohn P Williams, Jonathan P Thompson, John McDonald, et al.
Organic & Biomolecular Chemistry|May 20, 2017
Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptorSalvatore Pacifico, Aidan Kerckhoffs, Andrew J Fallow, et al.
British Journal of Pharmacology|April 6, 2023
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cellsMark F Bird, Christopher P Hebbes, Anushuya Tamang, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 23, 2008
Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptorsMassimo Ibba, Masato Kitayama, John McDonald, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 4, 2007
Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamineZoë L S Brookes, Emily N Stedman, Remo Guerrini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 2014
Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladderEvangelia Bakali, Ruth A Elliott, Anthony H Taylor, et al.
Neuroscience Letters|April 4, 2003
Lack of an interaction between orexinergic and opioid/nociceptinergic systems in rat cerebrocortical slicesKazuyoshi Hirota, Tetsuya Kushikata, Mihoko Kudo, et al.
Journal of Neurochemistry|April 20, 2007
Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell deathPatricia M W Lam, Atticus H Hainsworth, Graham D Smith, et al.
Molecules (Basel, Switzerland)|December 30, 2020
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor ActivationJustyna Piekielna-Ciesielska, Roberto Artali, Ammar A H Azzam, et al.
CNS Drug Reviews|July 12, 2005
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptorGirolamo Calo, Remo Guerrini, Anna Rizzi, et al.
Anesthesia and Analgesia|September 28, 2007
Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptorsJohn P Williams, Jonathan P Thompson, John McDonald, et al.
Organic & Biomolecular Chemistry|May 20, 2017
Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptorSalvatore Pacifico, Aidan Kerckhoffs, Andrew J Fallow, et al.
British Journal of Pharmacology|April 6, 2023
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cellsMark F Bird, Christopher P Hebbes, Anushuya Tamang, et al.
Pageof 10